Life Sciences
Six leadership editions
The Knowledge Is Walking Out
Your pipeline velocity depends on three to five specialists whose knowledge lives in their heads, not in any system. What happens when the next one leaves?
What's Changing in Your Programme Capital Story
Your next €100M of capital. The forecast you sign. The thesis your specialist-fund investors can recite back. Three questions that look separate, but are actually one. A briefing for CFOs at mid-market European life sciences firms.
What's Changing in Your Specialist Operations
Your specialist bench has not grown. Your programme load has. Your senior regulatory director is the bottleneck on three submissions simultaneously. Three problems that look separate, but are actually one. A briefing for operations leaders at life sciences firms.
What's Changing in the Specialist Bench You're Building
Your principal scientists are watching. Your regulatory writing layer has quietly compressed. Your 2030 senior bench is being shaped by decisions you were not invited to. A briefing for Chief Human Resources Officers at mid-market European life sciences firms.
What's Changing on Your Commercial Floor
Your uptake curve is flattening. Your MSLs are falling behind KOLs who arrive briefed by their own AI. Two of your best specialists are on competitors' lists. A briefing for commercial leaders at European life sciences affiliates.
What's Changing Underneath Your Validated Stack
Your digital R&D budget is two instruments pretending to be one. Your platform sits above a model layer that commoditises every eighteen months. Your scorecard measures system uptime, validation status, and submission turnaround, and none of those is the 2026 question. A briefing for CTOs, CPOs, and Heads of Digital R&D at mid-market European life sciences firms.